Melissa Alegre, Ph.D. - Publications

Affiliations: 
2013 Molecular Biology Brigham Young University, Provo, UT, United States 
Area:
Oncology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Xiao M, Helsing AV, Lynch PM, El-Naggar A, Alegre MM, Robison RA, O'Neill KL. DNA damage caused by inorganic particulate matter on Raji and HepG2 cell lines exposed to ultraviolet radiation. Mutation Research. Genetic Toxicology and Environmental Mutagenesis. 771: 6-14. PMID 25308436 DOI: 10.1016/J.Mrgentox.2014.06.004  0.384
2014 Alegre MM, Weyant MJ, Bennett DT, Yu JA, Ramsden MK, Elnaggar A, Robison RA, O'Neill KL. Serum detection of thymidine kinase 1 as a means of early detection of lung cancer. Anticancer Research. 34: 2145-51. PMID 24778016  0.446
2013 Alegre MM, Knowles MH, Robison RA, O'Neill KL. Mechanics behind breast cancer prevention - focus on obesity, exercise and dietary fat. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 2207-12. PMID 23725113 DOI: 10.7314/Apjcp.2013.14.4.2207  0.437
2013 Alegre MM, Robison RA, O'Neill KL. Thymidine Kinase 1: A Universal Marker for Cancer Cancer and Clinical Oncology. 2. DOI: 10.5539/Cco.V2N1P159  0.483
2012 Alegre MM, Robison RA, O'Neill KL. Thymidine kinase 1 upregulation is an early event in breast tumor formation. Journal of Oncology. 2012: 575647. PMID 22778736 DOI: 10.1155/2012/575647  0.461
2012 Alegre M, Germann BL, Leavitt M, Eggett D, Killpack N, Burton S, Orton A, Leavitt C, O'Neill KL. Abstract 5528: Setting the clock: Tumor TK1 is a prognostic marker for disease recurrence Cancer Research. 72: 5528-5528. DOI: 10.1158/1538-7445.Am2012-5528  0.359
Show low-probability matches.